Stephen A. Hill, Director at Lipocine Inc. (LPCN), bought 4,000 shares at $4.95 ($20K) on 2014-11-13, disclosed to the SEC on 2014-11-13.
Open-market purchase of $20k LPCN by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| LPCN | SELL | 2018-01-02 | $4K | — | Filing → |
| CLRB | BUY | 2016-04-21 | $20K | — | Filing → |
| CBIO | BUY | 2015-12-18 | $10K | — | Filing → |